• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狂犬病:预防策略的改变和病理生理学的新认识。

Rabies: changing prophylaxis and new insights in pathophysiology.

机构信息

Paris-Saclay Institute of Neuroscience (UMR9197) CNRS - Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France.

Thai Red Cross Society Emerging Infectious Disease Health Science Centre and World Health Organization Collaborating Centre for Research and Training on Viral Zoonoses, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Curr Opin Infect Dis. 2018 Feb;31(1):93-101. doi: 10.1097/QCO.0000000000000420.

DOI:10.1097/QCO.0000000000000420
PMID:29293476
Abstract

PURPOSE OF REVIEW

Despite great progress in decoding disease mechanisms, rabies remains one of the leading causes of human death worldwide. Towards the elimination of human rabies deaths by 2030, feasible and affordable post (PEP) and pre-exposure prophylaxis (PrEP) must be available with expansion to rural areas in rabies endemic countries. Vaccination and population control of dogs, principal reservoirs and transmitters, must be done in concert.

RECENT FINDING

Advances in the understanding of rabies neuropathogenesis and pathophysiology are reviewed, including recent experimental findings on host- and virus-specific mechanisms mediating neuronal survival and explaining clinical differences in furious and paralytic rabies. The forthcoming World Health Organization guide on rabies based on pathogenesis and immunization mechanisms data with support by clinical evidence provide new accelerated 1 week intradermal PrEP and PEP schedules. Rabies immunoglobulin injected into the wound only is endorsed at amounts not exceeding the dose interfering with active immunization. Potential therapeutics as designed in accord with rabies neuro-pathophysiology are plausible.

SUMMARY

Clinical practice and rabies awareness can be leveraged by transboundary collaboration among different areas. Advancement in prophylaxis and perspectives on animal control offer a new path to conquer rabies by 2030.

摘要

目的综述

尽管在破译疾病机制方面取得了重大进展,但狂犬病仍是全球导致人类死亡的主要原因之一。为了在 2030 年消除人类狂犬病死亡病例,必须在狂犬病流行国家的农村地区提供可行和负担得起的接触后(PEP)和接触前预防(PrEP)。必须协调开展犬(主要的储存宿主和传播媒介)的免疫接种和种群控制。

最新发现

本文回顾了对狂犬病神经发病机制和病理生理学的理解进展,包括关于宿主和病毒特异性机制的最新实验发现,这些机制介导神经元存活,并解释了狂躁型和麻痹型狂犬病的临床差异。即将发布的世界卫生组织狂犬病指南基于发病机制和免疫机制数据,并得到临床证据的支持,提供了新的加速一周皮内 PrEP 和 PEP 方案。仅在伤口处注射狂犬病免疫球蛋白的剂量不得超过干扰主动免疫的剂量,这一建议得到了认可。根据狂犬病的神经病理生理学设计的潜在治疗方法是合理的。

总结

通过不同领域的跨境合作,可以利用狂犬病的临床实践和认识来推动进展。预防措施的进步和对动物控制的看法为 2030 年消灭狂犬病提供了新途径。

相似文献

1
Rabies: changing prophylaxis and new insights in pathophysiology.狂犬病:预防策略的改变和病理生理学的新认识。
Curr Opin Infect Dis. 2018 Feb;31(1):93-101. doi: 10.1097/QCO.0000000000000420.
2
Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.色谱纯化vero 细胞狂犬病疫苗用于皮内暴露前和暴露后狂犬病预防的安全性和免疫原性。
Expert Rev Vaccines. 2014 Dec;13(12):1593-601. doi: 10.1586/14760584.2014.971764. Epub 2014 Oct 15.
3
Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings.关于在地方病流行地区开展犬类疫苗接种“同一健康”计划作为控制人畜共患狂犬病最具成本效益手段的基本原理及依据。
Vaccine. 2017 Mar 23;35(13):1668-1674. doi: 10.1016/j.vaccine.2017.02.014. Epub 2017 Feb 16.
4
Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12.前往狂犬病流行国家的旅行者是否应该进行暴露前疫苗接种?对 2000-12 年前往狂犬病流行国家的丹麦旅行者进行的暴露后预防和暴露前预防的评估。
J Travel Med. 2016 May 4;23(4). doi: 10.1093/jtm/taw022. Print 2016 Apr.
5
Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review.预防狂犬病所有措施的成本效益建模研究:系统综述。
Vaccine. 2019 Oct 3;37 Suppl 1:A146-A153. doi: 10.1016/j.vaccine.2018.11.071. Epub 2018 Dec 13.
6
New human rabies vaccines in the pipeline.新型人用狂犬病疫苗正在研发中。
Vaccine. 2019 Oct 3;37 Suppl 1(Suppl 1):A140-A145. doi: 10.1016/j.vaccine.2018.08.039. Epub 2018 Aug 25.
7
Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).儿童狂犬病暴露前预防接种纯化鸡胚细胞疫苗(PCECV)。
Hum Vaccin Immunother. 2013 Jul;9(7):1454-9. doi: 10.4161/hv.24502. Epub 2013 Apr 9.
8
WHO's new rabies recommendations: implications for high incidence countries.世卫组织新的狂犬病建议:对高发国家的影响。
Curr Opin Infect Dis. 2019 Oct;32(5):401-406. doi: 10.1097/QCO.0000000000000578.
9
Progress towards rabies control and elimination in Vietnam.越南在狂犬病控制与消除方面取得的进展。
Rev Sci Tech. 2019 May;38(1):199-212. doi: 10.20506/rst.38.1.2953.
10
Cost-effectiveness of rabies post exposure prophylaxis in Iran.伊朗狂犬病暴露后预防的成本效益
J Res Health Sci. 2014 Spring;14(2):122-7.

引用本文的文献

1
Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization.通过狂犬病病毒糖蛋白(RABV-G)结构域筛选和异源初免-加强免疫优化狂犬病信使核糖核酸(mRNA)疫苗效力
NPJ Vaccines. 2025 Mar 2;10(1):43. doi: 10.1038/s41541-025-01098-w.
2
Immunological findings of West Caucasian bat virus in an accidental host.西高加索蝙蝠病毒在意外宿主中的免疫学发现。
J Virol. 2025 Feb 25;99(2):e0191424. doi: 10.1128/jvi.01914-24. Epub 2025 Jan 23.
3
Dendritic pathology and overexpression of MAP2 in Purkinje cells from mice inoculated with rabies virus.
接种狂犬病病毒的小鼠浦肯野细胞中的树突状病理变化及微管相关蛋白2(MAP2)的过表达
J Mol Histol. 2024 Dec 30;56(1):62. doi: 10.1007/s10735-024-10348-5.
4
Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate.自组装纳米颗粒由自噬体铁蛋白复合物工程化制成,作为狂犬病病毒疫苗候选物。
Nat Commun. 2024 Oct 4;15(1):8601. doi: 10.1038/s41467-024-52908-z.
5
Toward the Development of a Pan-Lyssavirus Vaccine.开发泛狂犬病病毒疫苗。
Viruses. 2024 Jul 10;16(7):1107. doi: 10.3390/v16071107.
6
Application prospects of the 2BS cell-adapted China fixed rabies virus vaccine strain 2aG4-B40.2BS 细胞适应株狂犬病病毒疫苗株 2aG4-B40 的应用前景。
Virol J. 2024 Jul 8;21(1):154. doi: 10.1186/s12985-024-02416-9.
7
Is there an association between peri-diagnostic vaccination and clinical outcomes in COVID-19 patients?新冠病毒感染患者诊断前后接种疫苗与临床结局之间是否存在关联?
Antimicrob Steward Healthc Epidemiol. 2023 Sep 8;3(1):e150. doi: 10.1017/ash.2023.417. eCollection 2023.
8
An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs.一种基于 mRNA 的狂犬病疫苗可在小鼠和犬中诱导强烈的保护性免疫应答。
Virol J. 2022 Nov 12;19(1):184. doi: 10.1186/s12985-022-01919-7.
9
Longitudinal Tracing of Lyssavirus Infection in Mice via In Vivo Bioluminescence Imaging.通过体内生物发光成像对小鼠狂犬病病毒感染进行纵向追踪
Methods Mol Biol. 2022;2524:369-394. doi: 10.1007/978-1-0716-2453-1_30.
10
A One Medicine Mission for an Effective Rabies Therapy.一项关于有效狂犬病治疗的“同一医学”使命。
Front Vet Sci. 2022 Mar 16;9:867382. doi: 10.3389/fvets.2022.867382. eCollection 2022.